Company profile for Axol Bioscience

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Axol produces high quality human cell products and critical reagents such as media and growth supplements. We have a passion for great science, delivering epic support and innovating future products to help our customers advance faster in their research. Our expertise includes reprogramming cells to iPSCs and then differentiating to various cell types. We supply differentiated cells derived from healthy donors and patients ...
Axol produces high quality human cell products and critical reagents such as media and growth supplements. We have a passion for great science, delivering epic support and innovating future products to help our customers advance faster in their research. Our expertise includes reprogramming cells to iPSCs and then differentiating to various cell types. We supply differentiated cells derived from healthy donors and patients of specific disease backgrounds.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
The Science Village | Chesterford Research Park, Cambridge, Cambridgeshire CB1...
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

BPI Europe

BPI Europe

Not Confirmed

envelop Contact Supplier

BPI Europe

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.indianpharmapost.com/news/axol-bioscience-acquires-ophthalmology-business-from-newcells-biotech-19153

INDPHARMAPOST
19 Feb 2026

https://www.contractpharma.com/breaking-news/axol-bioscience-secures-2-8m-for-u-s-expansion-product-development/

CONTRACTPHARMA
13 Jan 2026

https://www.businesswire.com/news/home/20241021648590/en

BUSINESSWIRE
21 Oct 2024

https://www.sygnaturediscovery.com/news-and-events/news/sygnature-discovery-collaborates-with-axol-bioscience-to-utilize-human-ipsc-derived-microglial-cells-in-high-content-imaging-drug-discovery-screening-workflows/

PRESS RELEASE
10 Oct 2023

https://www.businesswire.com/news/home/20230606005794/en

BUSINESSWIRE
07 Jun 2023

https://www.businesswire.com/news/home/20220607005976/en

BUSINESSWIRE
07 Jun 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty